Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Apr;69(4):2075–2081. doi: 10.1128/jvi.69.4.2075-2081.1995

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.

G Palladino 1, K Mozdzanowska 1, G Washko 1, W Gerhard 1
PMCID: PMC188873  PMID: 7884853

Abstract

The ability of monoclonal antibodies (MAbs) to passively cure an influenza virus pneumonia in the absence of endogenous T- and B-cell responses was investigated by treating C.B-17 mice, homozygous for the severe combined immunodeficiency (SCID) mutation, with individual monoclonal antiviral antibodies 1 day after pulmonary infection with influenza virus PR8 [A/PR/8/34 (H1N1)]. Less than 10% of untreated SCID mice survived the infection. By contrast, 100% of infected SCID mice that had been treated with a single intraperitoneal inoculation of at least 175 micrograms of a pool of virus-neutralizing (VN+) antihemagglutinin (anti-HA) MAbs survived, even if antibody treatment was delayed up to 7 days after infection. The use of individual MAbs showed that recovery could be achieved by VN+ anti-HA MAbs of the immunoglobulin G1 (IgG1), IgG2a, IgG2b, and IgG3 isotypes but not by VN+ anti-HA MAbs of the IgA and IgM isotypes, even if the latter were used in a chronic treatment protocol to compensate for their shorter half-lives in vivo. Both IgA and IgM, although ineffective therapeutically, protected against infection when given prophylactically, i.e., before exposure to virus. An Fc gamma-specific effector mechanism was not an absolute requirement for antibody-mediated recovery, as F(ab')2 preparations of IgGs could cure the disease, although with lesser efficacy, than intact IgG. An anti-M2 MAb of the IgG1 isotype, which was VN- but bound well to infected cells and inhibited virus growth in vitro, failed to cure. These observations are consistent with the idea that MAbs of the IgG isotype cure the disease by neutralizing all progeny virus until all productively infected host cells have died. VN+ MAbs of the IgA and IgM isotypes may be ineffective therapeutically because they do not have sufficient access to all tissue sites in which virus is produced during influenza virus pneumonia.

Full Text

The Full Text of this article is available as a PDF (235.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ada G. L., Jones P. D. The immune response to influenza infection. Curr Top Microbiol Immunol. 1986;128:1–54. doi: 10.1007/978-3-642-71272-2_1. [DOI] [PubMed] [Google Scholar]
  2. Allan W., Tabi Z., Cleary A., Doherty P. C. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol. 1990 May 15;144(10):3980–3986. [PubMed] [Google Scholar]
  3. Baldridge J. R., Buchmeier M. J. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J Virol. 1992 Jul;66(7):4252–4257. doi: 10.1128/jvi.66.7.4252-4257.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bender B. S., Croghan T., Zhang L., Small P. A., Jr Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med. 1992 Apr 1;175(4):1143–1145. doi: 10.1084/jem.175.4.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Binder D., Kündig T. M. Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. J Immunol. 1991 Jun 15;146(12):4301–4307. [PubMed] [Google Scholar]
  6. Bodmer H., Obert G., Chan S., Benoist C., Mathis D. Environmental modulation of the autonomy of cytotoxic T lymphocytes. Eur J Immunol. 1993 Jul;23(7):1649–1654. doi: 10.1002/eji.1830230738. [DOI] [PubMed] [Google Scholar]
  7. Bosma M. J., Carroll A. M. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol. 1991;9:323–350. doi: 10.1146/annurev.iy.09.040191.001543. [DOI] [PubMed] [Google Scholar]
  8. Caton A. J., Brownlee G. G., Yewdell J. W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 1982 Dec;31(2 Pt 1):417–427. doi: 10.1016/0092-8674(82)90135-0. [DOI] [PubMed] [Google Scholar]
  9. Cerny A., Sutter S., Bazin H., Hengartner H., Zinkernagel R. M. Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice. J Virol. 1988 May;62(5):1803–1807. doi: 10.1128/jvi.62.5.1803-1807.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Couch R. B., Kasel J. A. Immunity to influenza in man. Annu Rev Microbiol. 1983;37:529–549. doi: 10.1146/annurev.mi.37.100183.002525. [DOI] [PubMed] [Google Scholar]
  11. Denkers E. Y., Badger C. C., Ledbetter J. A., Bernstein I. D. Influence of antibody isotype on passive serotherapy of lymphoma. J Immunol. 1985 Sep;135(3):2183–2186. [PubMed] [Google Scholar]
  12. Doherty P. C., Allan W., Eichelberger M., Carding S. R. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol. 1992;10:123–151. doi: 10.1146/annurev.iy.10.040192.001011. [DOI] [PubMed] [Google Scholar]
  13. Eichelberger M., Allan W., Zijlstra M., Jaenisch R., Doherty P. C. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med. 1991 Oct 1;174(4):875–880. doi: 10.1084/jem.174.4.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Eis-Hübinger A. M., Schmidt D. S., Schneweis K. E. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J Gen Virol. 1993 Mar;74(Pt 3):379–385. doi: 10.1099/0022-1317-74-3-379. [DOI] [PubMed] [Google Scholar]
  15. Fujinami R. S., Rosenthal A., Lampert P. W., Zurbriggen A., Yamada M. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J Virol. 1989 May;63(5):2081–2087. doi: 10.1128/jvi.63.5.2081-2087.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gaertner D. J., Jacoby R. O., Paturzo F. X., Johnson E. A., Brandsma J. L., Smith A. L. Modulation of lethal and persistent rat parvovirus infection by antibody. Arch Virol. 1991;118(1-2):1–9. doi: 10.1007/BF01311299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gerhard W., Yewdell J., Frankel M. E., Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature. 1981 Apr 23;290(5808):713–717. doi: 10.1038/290713a0. [DOI] [PubMed] [Google Scholar]
  18. Graham B. S., Bunton L. A., Rowland J., Wright P. F., Karzon D. T. Respiratory syncytial virus infection in anti-mu-treated mice. J Virol. 1991 Sep;65(9):4936–4942. doi: 10.1128/jvi.65.9.4936-4942.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Griffin D. E., Johnson R. T. Role of the immune response in recovery from Sindbis virus encephalitis in mice. J Immunol. 1977 Mar;118(3):1070–1075. [PubMed] [Google Scholar]
  20. Griffin D. E., Levine B., Tyor W. R., Irani D. N. The immune response in viral encephalitis. Semin Immunol. 1992 Apr;4(2):111–119. [PubMed] [Google Scholar]
  21. Hinshaw V. S., Olsen C. W., Dybdahl-Sissoko N., Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol. 1994 Jun;68(6):3667–3673. doi: 10.1128/jvi.68.6.3667-3673.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hunt A. R., Short W. A., Johnson A. J., Bolin R. A., Roehrig J. T. Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology. 1991 Nov;185(1):281–290. doi: 10.1016/0042-6822(91)90775-7. [DOI] [PubMed] [Google Scholar]
  23. Iwasaki T., Nozima T. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. J Immunol. 1977 Jan;118(1):256–263. [PubMed] [Google Scholar]
  24. Jackson D. C., Tang X. L., Murti K. G., Webster R. G., Tregear G. W., Bean W. J. Electron microscopic evidence for the association of M2 protein with the influenza virion. Arch Virol. 1991;118(3-4):199–207. doi: 10.1007/BF01314030. [DOI] [PubMed] [Google Scholar]
  25. Kaminski M. S., Kitamura K., Maloney D. G., Campbell M. J., Levy R. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol. 1986 Feb 1;136(3):1123–1130. [PubMed] [Google Scholar]
  26. Kavaler J., Caton A. J., Staudt L. M., Gerhard W. A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. Eur J Immunol. 1991 Nov;21(11):2687–2695. doi: 10.1002/eji.1830211107. [DOI] [PubMed] [Google Scholar]
  27. Kino Y., Hayashi Y., Hayashida I., Mori R. Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection. J Gen Virol. 1982 Dec;63(2):475–479. doi: 10.1099/0022-1317-63-2-475. [DOI] [PubMed] [Google Scholar]
  28. Kipps T. J., Parham P., Punt J., Herzenberg L. A. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med. 1985 Jan 1;161(1):1–17. doi: 10.1084/jem.161.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kris R. M., Asofsky R., Evans C. B., Small P. A., Jr Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J Immunol. 1985 Feb;134(2):1230–1235. [PubMed] [Google Scholar]
  30. Kris R. M., Yetter R. A., Cogliano R., Ramphal R., Small P. A. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. Immunology. 1988 Mar;63(3):349–353. [PMC free article] [PubMed] [Google Scholar]
  31. Lamb R. A., Zebedee S. L., Richardson C. D. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell. 1985 Mar;40(3):627–633. doi: 10.1016/0092-8674(85)90211-9. [DOI] [PubMed] [Google Scholar]
  32. Levine B., Hardwick J. M., Trapp B. D., Crawford T. O., Bollinger R. C., Griffin D. E. Antibody-mediated clearance of alphavirus infection from neurons. Science. 1991 Nov 8;254(5033):856–860. doi: 10.1126/science.1658936. [DOI] [PubMed] [Google Scholar]
  33. Lightman S., Cobbold S., Waldmann H., Askonas B. A. Do L3T4+ T cells act as effector cells in protection against influenza virus infection. Immunology. 1987 Sep;62(1):139–144. [PMC free article] [PubMed] [Google Scholar]
  34. Mazanec M. B., Nedrud J. G., Kaetzel C. S., Lamm M. E. A three-tiered view of the role of IgA in mucosal defense. Immunol Today. 1993 Sep;14(9):430–435. doi: 10.1016/0167-5699(93)90245-G. [DOI] [PubMed] [Google Scholar]
  35. Murphy B. R., Clements M. L. The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol. 1989;146:107–116. doi: 10.1007/978-3-642-74529-4_12. [DOI] [PubMed] [Google Scholar]
  36. Nagafuchi S., Oda H., Mori R., Taniguchi T. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice. J Gen Virol. 1979 Sep;44(3):715–723. doi: 10.1099/0022-1317-44-3-715. [DOI] [PubMed] [Google Scholar]
  37. Perry L. L., Lodmell D. L. Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J Virol. 1991 Jul;65(7):3429–3434. doi: 10.1128/jvi.65.7.3429-3434.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Prince G. A., Horswood R. L., Chanock R. M. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol. 1985 Sep;55(3):517–520. doi: 10.1128/jvi.55.3.517-520.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Renegar K. B., Small P. A., Jr Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol. 1991 Mar 15;146(6):1972–1978. [PubMed] [Google Scholar]
  40. Scherle P. A., Palladino G., Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol. 1992 Jan 1;148(1):212–217. [PubMed] [Google Scholar]
  41. Schlesinger J. J., Foltzer M., Chapman S. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology. 1993 Jan;192(1):132–141. doi: 10.1006/viro.1993.1015. [DOI] [PubMed] [Google Scholar]
  42. Schulman J. L., Petigrow C., Woodruff J. Effects of cell mediated immunity in influenza virus infection in mice. Dev Biol Stand. 1977 Jun 1;39:385–390. [PubMed] [Google Scholar]
  43. Shanley J. D., Jordan M. C., Stevens J. G. Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis. 1981 Feb;143(2):231–237. doi: 10.1093/infdis/143.2.231. [DOI] [PubMed] [Google Scholar]
  44. Simmons A., Nash A. A. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J Infect Dis. 1987 Apr;155(4):649–654. doi: 10.1093/infdis/155.4.649. [DOI] [PubMed] [Google Scholar]
  45. Sissons J. G., Oldstone M. B. Antibody-mediated destruction of virus-infected cells. Adv Immunol. 1980;29:209–260. doi: 10.1016/S0065-2776(08)60045-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Staats H. F., Oakes J. E., Lausch R. N. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells. J Virol. 1991 Nov;65(11):6008–6014. doi: 10.1128/jvi.65.11.6008-6014.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Takizawa T., Matsukawa S., Higuchi Y., Nakamura S., Nakanishi Y., Fukuda R. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol. 1993 Nov;74(Pt 11):2347–2355. doi: 10.1099/0022-1317-74-11-2347. [DOI] [PubMed] [Google Scholar]
  48. Turner G. S. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J Gen Virol. 1978 Sep;40(3):595–604. doi: 10.1099/0022-1317-40-3-595. [DOI] [PubMed] [Google Scholar]
  49. Vieira P., Rajewsky K. The half-lives of serum immunoglobulins in adult mice. Eur J Immunol. 1988 Feb;18(2):313–316. doi: 10.1002/eji.1830180221. [DOI] [PubMed] [Google Scholar]
  50. Virelizier J. L., Allison A. C., Schild G. C. Immune responses to influenza virus in the mouse, and their role in control of the infection. Br Med Bull. 1979 Jan;35(1):65–68. doi: 10.1093/oxfordjournals.bmb.a071544. [DOI] [PubMed] [Google Scholar]
  51. Virelizier J. L. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol. 1975 Aug;115(2):434–439. [PubMed] [Google Scholar]
  52. Walsh E. E., Schlesinger J. J., Brandriss M. W. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect Immun. 1984 Feb;43(2):756–758. doi: 10.1128/iai.43.2.756-758.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Worthington M., Conliffe M. A., Baron S. Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice. J Infect Dis. 1980 Aug;142(2):163–174. doi: 10.1093/infdis/142.2.163. [DOI] [PubMed] [Google Scholar]
  54. Wölfel T., Van Pel A., De Plaen E., Lurquin C., Maryanski J. L., Boon T. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay. Immunogenetics. 1987;26(3):178–187. doi: 10.1007/BF00365909. [DOI] [PubMed] [Google Scholar]
  55. Yewdell J. W., Webster R. G., Gerhard W. U. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature. 1979 May 17;279(5710):246–248. doi: 10.1038/279246a0. [DOI] [PubMed] [Google Scholar]
  56. Young D. F., Randall R. E., Hoyle J. A., Souberbielle B. E. Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J Virol. 1990 Nov;64(11):5403–5411. doi: 10.1128/jvi.64.11.5403-5411.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zebedee S. L., Lamb R. A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol. 1988 Aug;62(8):2762–2772. doi: 10.1128/jvi.62.8.2762-2772.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES